Counting for Cancer Podcast


Download Webinar

Counting for Cancer: Digital Detection of Rare Mutant DNA Molecules
Speaker: Kenneth W. Kinzler, Ph.D., Professor, Oncology; Director, Ludwig Center at Johns Hopkins University, The Johns Hopkins Kimmel Cancer Center
 

" Under licensing agreements between the companies listed below and the Johns Hopkins University, Dr. Kinzler is entitled to a share of royalty and milestone payments received by the University on sales of products related to previous and ongoing research in the lab. Dr. Kinzler also has ownership interest in Inostics and PGDx. The terms of these arrangements are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. 

PGDx, Inostics, Exact Sciences Corporation, Genzyme Corporation, Agencourt, GMP Companies, Morphotek, Calbiochem Novabiochem, Wyeth, Amgen, Merck, OncoMethylome Sciences, GanyMed, Bayer Corporation, 454 Life Sciences, Corixa Corp, Q-Biogene, Smithkline-Beecham, Stratagene, Yamanouchi Pharmaceuticals, Zymogenetics, Qbiogene, Quantum Biotech, Zymogenetics "  

 

* - required fields 


 
* First Name:    
* Last Name:    
Company Name:    
Company/Personal Website:   
* Email:    
* Phone (US or Canada):  Ext:   
* State/Province (US or Canada):   
* Country:    

 

Comments:  

   

 

By Series:
By Region: